The drugmaker has more than doubled todayThe Dow is lower today, dragged down by lackluster economic data. However, three stocks making notable moves higher today are drugmaker Bio-Path Holdings Inc (NASDAQ:BPTH), wearable tech firm Fitbit Inc (NYSE:FIT), and tech name Zayo Group Holdings Inc (NYSE:ZAYO). Here's a quick look at what's got the shares of BPTH, FIT, and ZAYO soaring today.BPTH R...Read More
SGS Canada is launching a new service for the metals and mining industry - Field Analytical Services and Testing (FAST), in North America and Australia. FAST provides real-time data acquisition in the field by pairing portable instrumentation and machine learning. It will bring instrumentation into the field, provide data within 24 to 48 hours and, with the use of machine learning, enable real-ti...Read More
The Goodman School of Mines at Laurentian University and the Core Foundation signed a memorandum of understanding this week aiming to promote the school's education and research activities in Peru, Chile and Brazil.Osman Abou-RabiaThe Core Foundation is a non-profit organization dedicated to create new knowledge, discovery and innovation in Latin America."Countries like Peru need our strong...Read More
The stock just pulled back to a historically bullish trendlineUnitedHealth Group Inc (NYSE:UNH) stock has taken a beating, after last week's Medicare-for-All bill was introduced by House Democrats -- wreaking havoc on the health insurers and helping to drag down the Dow on Monday. However, it appears the stock has found some support in the $235 area, which is around where it bottomed in late Dece...Read More
The stock is pacing for its worst week of 2019The shares of General Electric Company (NYSE:GE) have taken a beating this week, after CEO Larry Culp yesterday warned on this year's cash flow. As such, J.P. Morgan Securities analyst Stephen Tusa said his $6 price target on GE stock "looks generous," and CNBC's "Mad Money" host Jim Cramer compared the comments to dropping "a bomb on my head." Against...Read More
Busy news days are driving heavy options trading on these 3 stocksLooking at the options trading taking place today, three names jumping out due to unusual put volume are telecom concern Sprint Corp (NYSE:S), Dutch bank ING Groep NV (NYSE:ING), and solar issue JinkoSolar Holding Co., Ltd. (NYSE:JKS). Below is a breakdown of today's news and trading activity around shares of S, ING, and JKS. T-Mob...Read More
Calls continue to be the options of choice on I stockIntelsat SA (NYSE:I) surged 1,445% from its February 2018 intraday low at $2.44 to its Oct. 17 record high of $37.70. Since then, the stock has pulled back drastically, last seen trading at $18.50. Nevertheless, RBC said "this lower share price represents a great buying opportunity," and raised its rating on the communications satellite services...Read More
The U.S. trade deficit hit a 10-year highStocks are lower in afternoon trading, as investors continue to digest a lackluster ADP employment report and a 10-year high in the U.S. trade deficit. In addition, Wall Street continues to await news on U.S.-China trade talks, with President Donald Trump reportedly pushing for a resolution. At last check, the Dow Jones Industrial Average (DJI), S&P 500 Ind...Read More
Cronos Group stock has more than doubled in 2019Cronos Group Inc (NASDAQ:CRON) stock has been red-hot in 2019, already more than doubling in value and nabbing a record high of $25.10 on Feb. 4. Today, CRON is taking a breather, last seen down 3.2% to trade at $22.30. If history is any guide, though, Cronos options traders may want to set their sights on more record highs for the weed stock.Specifi...Read More
After weeks of carping at each other, representatives of Barrick Gold Corp. and Newmont Mining Corp. met on Tuesday. Just what happened remains unclear.A spokesman for Newmont called the meeting "productive and a good starting point." Barrick didn't immediately comment. The talk came a day after Newmont's board rejected Barrick's hostile takeover bid, and the target company's CEO said he'd be will...Read More
MYL is trading back above its year-to-date breakeven levelMylan NV (NASDAQ:MYL) is up 1.3% to trade at $27.75, after Morgan Stanley upgraded the EpiPen maker to "overweight" from "equal weight," while trimming its price target to $35 from $39. The brokerage firm said the stock is trading nearly "historical valuation lows," and is running at a discount to its sector peers. This follows last week's...Read More
Saudi Arabia announced $20 billion in infrastructure and energy investments for the cash-strapped country of 200 million, which is currently on the brink of financial crisis.Many of the projects are located in Pakistan's impoverished and restive Balochistan region, which lies along the 565-mile border with Saudi arch-rival Iran.Natasha Turak| @NatashaTurakPublished 15 Hours AgoUpdated9 Hours AgoCN...Read More
The company plans to expand production at the campusThe shares of Tilray Inc (NASDAQ:TLRY) are up 1.8% at $78.29 this morning, after the company reported that its Portuguese division's medical cannabis harvest was a success. Tilray said it has plans to expand production at the facility, with campus personnel expected to double by the end of this year. The stock is set to break its three-day losing...Read More
Year-to-date the security has shed 9%Online travel name TripAdvisor Inc (NASDAQ:TRIP) is lower in early trading, down 5.4% at $49.48, after being slammed with a bear note from Cowen and Company. The firm downgraded its rating to "underperform" from "market perform," and sliced its price target to $40 from $50. In the note, Cowen called out TripAdvisor's weak start to the year, the stock's expensi...Read More
The brokerage waxed optimistic on VYGR's gene therapy-based drug candidatesThe shares of Voyager Therapeutics Inc (NASDAQ:VYGR) jumped out of the gate, after Cantor Fitzgerald initiated coverage with an "outperform" rating and a $27 price target -- a 52% premium to last night's close at $17.76. The brokerage firm said the company's gene therapy-based drug candidates for a number of central nervous...Read More
Call open interest is at a 52-week high on CVS CVS Health Corp (NYSE:CVS) has been getting wrecked this year. The stock began its descent back in December, shortly after touching a 52-week high of $82.15, and then it suffered a massive post-earnings bear gap last month, and has continued to slide. In fact, CVS shares closed at their lowest point in over five years yesterday, settling at $54.96. At...Read More
The 2018 trade deficit rose to a 10-year highDow Jones Industrial Average (DJI) futures are below fair value this morning, as Wall Street awaits updates on U.S.-China trade talks. A Bloomberg report indicated President Donald Trump is pressuring officials in Washington to reach a deal soon in the hopes of boosting the stock market. Investors are also digesting the latest ADP employment report, whi...Read More
The current bull market rally turns 10 years old this weekExactly 10 years ago today, the S&P 500 Index (SPX) hit its lowest point of the financial crisis. The index has quadrupled since then. On an annualized basis, the S&P 500 has gained 15% per year over the past 10 years, which has only happened a few other times (we have S&P 500 data since 1929). Looking at the chart below, 15% for 10 years i...Read More
The average analyst price target looks way too high on PXD stockPioneer Natural Resources (NYSE:PXD) has been in a long-term downtrend since peaking above $210 in May. While the security has bounced from its late-December lows, it's run into a potential wall in the form of its 80-day moving average, which could smack PXD even lower. On the fundamental front, the company is in a transition period,...Read More
Dollar's recent climb is putting pressure on gold prices.Eurozone weakness is also adding to metal's short-term weakness.Improved emerging markets outlook should eventually bail gold out.A counter-trend rally in the U.S. dollar index is providing a headwind for gold and will likely keep the metal range-bound below its recent high for a few weeks. In today's report we'll review the factors...Read More